GABA ELISA
Technology | : ELISA |
Kit size | : 96 determinations |
Sample material | : urine, serum or plasma (EDTA) |
Sample preparation | : - |
Sample volume | : 100 µl urine; 300 µl serum, plasma (EDTA) |
Standard range | : 75-7500 ng/ml (urine); 25-2500 ng/ml (plasma) |
Incubation | : urine: 15, 10, 2h, 10, 2h, 30min (RT/shaker) |
Measuring system | : TMB at 450nm |
Sensitivity | : 25 ng/ml (urine), 7.5 ng/ml (plasma) |
Special remarks:
Intended use and principle of the test
Enzyme Immunoassay for the quantitative determination of Gamma-aminobutyric acid (GABA). After extraction and derivatization Gamma-aminobutyric acid (GABA) is quantitatively determined by ELISA. The competitive ELISA uses the microtiter plate format. The antigen is bound to the solid phase of the microtiter plate. The acylated standards, controls and samples and the solid phase bound analyte compete for a fixed number of antiserum binding sites. When the system is in equilibrium, free antigen and free antigen-antiserum complexes are removed by washing. The antibody bound to the solid phase is detected by an anti-rabbit IgG-peroxidase conjugate using TMB as a substrate. The reaction is monitored at 450 nm. Quantification of unknown samples is achieved by comparing their absorbance with a reference curve prepared with known standards.





